Valsartan is a widely-used prescription drug used to treat high blood pressure. It is also known by its generic name, Diovan. As with any medication, it is important to understand and follow the proper dosage instructions in order to ensure that your health remains safe. But how much Valsartan is too much? In this blog post, we’ll discuss what the right dose of Valsartan is and why it’s important to pay attention to the amount you take. We’ll also cover potential side effects of taking too much and how you can avoid them. Read on for more!
Valsartan is an angiotensin II receptor antagonist (ATRA) used to treat high blood pressure, congestive heart failure, and to reduce the risk of strokes. It works by relaxing blood vessels so that blood can flow more easily. It is also used in some patients after a heart attack. Valsartan can be taken with or without food.
Common side effects of Valsartan may include dizziness, headache, nausea, and diarrhea.
The recommended doses of Valsartan vary depending on the condition being treated. For hypertension, the usual recommended starting dose is 80 mg once daily. The dosage may be increased to a maximum of 320 mg once daily if needed. For congestive heart failure, the starting dose is 40 mg twice daily, with the dosage gradually increased as needed up to a maximum of 160 mg twice daily.
1. Dizziness
2. Lightheadedness
3. Fatigue
4. Nausea
5. Diarrhea
6. Headache
7. Dry mouth
8. Increased urination
If you are prescribed Valsartan, it is important to take the correct dose. The amount of medicine that you need to take may be different for different people.
If you miss a dose of Valsartan, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses of Valsartan at the same time.
Taking too much valsartan dosage can be dangerous, so it is important to understand the correct dosage for your condition.
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
The Higher the Disability Burden From Disease, the Higher the Suicide Risk
3.
Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
1.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
2.
Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources
3.
Enhancing Cancer Care: From Diagnosis Through Survivorship and Beyond
4.
Omentum Cancer: Causes, Symptoms, and Treatment Options
5.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation